Dezhan Healthcare Co

Dezhan Healthcare Co EPS

The Earnings per Share (EPS) of Dezhan Healthcare Co (000813.SZ) as of Oct 31, 2026 is -0.16 CNY. In the previous year, Earnings per Share (EPS) was -0.01 CNY — a change of 1,604.46% (lower).

EPS

-0.16CNY

YoY

1,604.46%

Last updated:

Earnings per Share (EPS) of Dezhan Healthcare Co is 2025 -0.16 CNY. Earnings per Share (EPS) of Dezhan Healthcare Co was 2024 -0.01 CNY. It decreases by 1,604.46% lower compared to the previous year.

The Dezhan Healthcare Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
0.42 CNY
Jan 1, 2019
0.15 CNY
Jan 1, 2020
0.13 CNY
Jan 1, 2021
-0.03 CNY
Jan 1, 2022
-0.02 CNY
Jan 1, 2023
0.04 CNY
Jan 1, 2024
-0.01 CNY
Jan 1, 2025
-0.16 CNY
The Dezhan Healthcare Co EPS history
YEAREPSYoY
-0.16CNY+1,604.46%
-0.01CNY-124.73%
0.04CNY-276.79%
-0.02CNY-15.30%
-0.03CNY-120.02%
0.13CNY-15.45%
0.15CNY-63.49%
0.42CNY+16.94%
0.36CNY-29.45%
0.50CNY-31.67%
0.74CNY+45.65%
0.51CNY+952.82%
0.05CNY-332.20%
-0.02CNY-430.51%
0.01CNY-57.83%
0.01CNY-117.24%
-0.09CNY-2,560.04%
0.00CNY-89.02%
0.03CNY+67.49%
0.02CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dezhan Healthcare Co Stock analysis

What does Dezhan Healthcare Co do? Dezhan Healthcare Co., Ltd. generates revenue through the development and sale of cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, and ecological water. The company's subsidiaries produce injections, biopharmaceuticals, and Chinese medicine preparations to optimize product structures and meet diverse market demands. Its primary market is China, where it targets consumers seeking health and wellness solutions through pharmaceutical and functional beverage offerings. The firm focuses on human life sciences research, emphasizing cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, and ecological water. Subsidiaries introduce production lines for multiple dosage forms, including injections, biopharmaceuticals, and Chinese medicine preparations, to enhance product variety and meet specific consumer needs within the Chinese market. Sales are driven by the domestic demand for health-focused pharmaceutical and beverage products. Dezhan Healthcare Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dezhan Healthcare Co stock

Earnings per Share (EPS) of Dezhan Healthcare Co is -0.16 CNY in 2025.

Earnings per Share (EPS) of Dezhan Healthcare Co changed from -0.01 CNY to -0.16 CNY, representing a 1,604.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Dezhan Healthcare Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Dezhan Healthcare Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Dezhan Healthcare Co